Symbiotec Pharmalab Limited
MainboardlistedSYMBIOTECINE899I01028- DRHP filed24 Dec 25
- RHP filed19 Aug 26
- Open24 Aug 26
- Close27 Aug 26
- Listed01 Sep 26
Issue
- Price band
- ₹938–988
- Issue price
- ₹988
- Face value
- ₹2
- Lot size
- 15
- Issue size
- ₹1,757 Cr
- Fresh / OFS
- ₹150.27 Cr / ₹1,606.72 Cr
- Issue type
- book built
- Registrar
- MUFG Intime India Private Limited
- Exchanges
- BSE, NSE
- Sector
- Healthcare
- Industry
- Pharmaceuticals
Returns
- Listing
- +11.1%
- 1 month
- +21.3%
- Current (03 Nov 26)
- +27.8%
Financials · from the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Borrowings | Total assets |
|---|---|---|---|---|---|---|
| FY24 | 716.2 | |||||
| FY25 | 751.6 | |||||
| FY26 | 869.1 |
Reservation · share of the net issue the offer document allocates to each category
- qib
- 50%
- nii
- 15%
- retail
- 35%
Subscription
| Category | Exchange | Times subscribed |
|---|---|---|
| bnii | combined | 82.92× |
| employee | combined | 15.41× |
| nii | combined | 73.63× |
| qib | combined | 172.03× |
| retail | combined | 12.96× |
| snii | combined | 55.07× |
| total | combined | 71.26× |
Lead managers
Avendus Capital Private Limited · JM Financial Limited · Motilal Oswal Investment Advisors Limited · Nomura Financial Advisory and Securities (India) Private Limited